These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. beta-blocker improvement in diastolic performance: the yin and yang of ventricular function changes. Eichhorn EJ; Grayburn PA Am Heart J; 2000 Apr; 139(4):584-6. PubMed ID: 10740138 [No Abstract] [Full Text] [Related]
4. Carvedilol for heart failure: more than just a beta-blocker? Cleland JG Br J Hosp Med; 1997 Nov 19-Dec 9; 58(10):493-7. PubMed ID: 10193451 [TBL] [Abstract][Full Text] [Related]
5. New evidence from the CAPRICORN Trial: the role of carvedilol in high-risk, post-myocardial infarction patients. Sackner-Bernstein JD Rev Cardiovasc Med; 2003; 4 Suppl 3():S25-9. PubMed ID: 14564231 [TBL] [Abstract][Full Text] [Related]
6. Effect of carvedilol therapy on functional mitral regurgitation, ventricular remodeling, and contractility in patients with heart failure due to left ventricular systolic dysfunction. Comin-Colet J; Sánchez-Corral MA; Manito N; Gómez-Hospital JA; Roca J; Fernández-Nofrerias E; Valdovinos P; Esplugas E Transplant Proc; 2002 Feb; 34(1):177-8. PubMed ID: 11959238 [No Abstract] [Full Text] [Related]
7. [Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomized trial]. Costalunga A; Gavazzi A Ital Heart J Suppl; 2001 Nov; 2(11):1246-7. PubMed ID: 11775420 [No Abstract] [Full Text] [Related]
8. Switching to once-daily evidence-based [beta]-blockers in patients with systolic heart failure or left ventricular dysfunction after myocardial infarction. Albert NM Crit Care Nurse; 2007 Dec; 27(6):62-72. PubMed ID: 18032686 [No Abstract] [Full Text] [Related]
9. Design and methodology of the CAPRICORN trial - a randomised double blind placebo controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction. Dargie HJ Eur J Heart Fail; 2000 Sep; 2(3):325-32. PubMed ID: 10938495 [No Abstract] [Full Text] [Related]
10. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy. Lee YC Am J Cardiol; 1997 Apr; 79(7):1001. PubMed ID: 9104927 [No Abstract] [Full Text] [Related]
11. Pronounced improvement in systolic and diastolic ventricular long axis function after treatment with metoprolol. Grüner Sveälv B; Täng MS; Waagstein F; Andersson B Eur J Heart Fail; 2007; 9(6-7):678-83. PubMed ID: 17448723 [TBL] [Abstract][Full Text] [Related]
12. Ventricular remodeling in heart failure and the effect of beta-blockade. Udelson JE Am J Cardiol; 2004 May; 93(9A):43B-8B. PubMed ID: 15144937 [TBL] [Abstract][Full Text] [Related]
14. Prediction of beneficial effect of beta blocker treatment in severe ischaemic cardiomyopathy: assessment of global left ventricular ejection fraction using dobutamine stress cardiovascular magnetic resonance. Kaandorp TA; Lamb HJ; Bax JJ; Boersma E; Viergever EP; van der Wall EE; de Roos A Heart; 2005 Nov; 91(11):1471-2. PubMed ID: 16230448 [No Abstract] [Full Text] [Related]
15. Letters to the editor: comments on the BEAUTIfUL study. Bonny A; Yitemben IM; Hamdaoui B; Larrazet F Cardiovasc J Afr; 2008; 19(6):323-24, discussion 324. PubMed ID: 19104735 [No Abstract] [Full Text] [Related]